Hangzhou Tigermed Consulting is a leading global Contract Research Organization (CRO). The company supports the healthcare industry with full-service solutions in clinical development, regulatory affairs, and biostatistical analysis, helping to accelerate the delivery of medical innovations.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Hangzhou Tigermed Consulting A is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Hangzhou Tigermed Consulting A last reported quarterly earnings on 8/28/2026 (Q2 2026). Earnings per share (EPS) came in at -0.54 CNY.
Across its last 4 earnings reports, Hangzhou Tigermed Consulting A stock moved by ±1.6% on average the following day. The largest reaction was +2.7% on 04/28/2026; 2 of 4 reactions were positive.
Hangzhou Tigermed Consulting A has beaten analyst EPS estimates in 1 of its last 6 evaluated quarters (beat rate: 16.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.